Literature DB >> 8156399

Opposite changes in the mesolimbic dopamine metabolism in the nerve terminal and cell body sites induced by locally infused baclofen in the rat.

M Yoshida1, H Yokoo, T Tanaka, H Emoto, M Tanaka.   

Abstract

Infusion of baclofen (10(-4) M, 1 h) into the ventral tegmental area (VTA), the cell body site of mesolimbic dopamine (DA) neuron system in conscious rats, caused a decrease in both axonal and somatodendritic DA release in this neuron system, when monitored by in vivo microdialysis using two probes simultaneously placed in both the NAC and the VTA. Levels of the metabolite of DA, 3,4-dihydroxyphenylacetic acid (DOPAC) in the VTA decreased significantly in a similar manner following infused baclofen into the VTA, however, a pronounced increase in DOPAC outflow was observed in dialysates from the NAC. This dissociated changes in DA metabolism observed in the NAC may possibly be derived from regulatory mechanisms via an autoreceptor located in the DA nerve terminals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8156399     DOI: 10.1016/0006-8993(94)90183-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  18 in total

1.  Interactions between dopamine and GABA in the control of ambulatory activity.

Authors:  A Agmo; C Belzung; M Giordano
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area.

Authors:  Arthur C Riegel; Carl R Lupica
Journal:  J Neurosci       Date:  2004-12-08       Impact factor: 6.167

3.  Glutamate and GABA modulate dopamine in the pedunculopontine tegmental nucleus.

Authors:  Björn Steiniger; Beate D Kretschmer
Journal:  Exp Brain Res       Date:  2003-02-26       Impact factor: 1.972

Review 4.  Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulation.

Authors:  Giovanni Addolorato; Lorenzo Leggio; F Woodward Hopf; Marco Diana; Antonello Bonci
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

Review 5.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

6.  Attenuation of d-amphetamine self-administration by baclofen in the rat: behavioral and neurochemical correlates.

Authors:  Karen Brebner; Soyon Ahn; Anthony G Phillips
Journal:  Psychopharmacology (Berl)       Date:  2004-07-22       Impact factor: 4.530

7.  Inactivation of the maternal fragile X gene results in sensitization of GABAB receptor function in the offspring.

Authors:  Bojana Zupan; Miklos Toth
Journal:  J Pharmacol Exp Ther       Date:  2008-09-23       Impact factor: 4.030

8.  Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans.

Authors:  Joshua A Lile; William W Stoops; Timothy S Allen; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Psychopharmacology (Berl)       Date:  2003-09-19       Impact factor: 4.530

9.  Antagonism of GABA-B but not GABA-A receptors in the VTA prevents stress- and intra-VTA CRF-induced reinstatement of extinguished cocaine seeking in rats.

Authors:  Jordan M Blacktop; Oliver Vranjkovic; Matthieu Mayer; Matthew Van Hoof; David A Baker; John R Mantsch
Journal:  Neuropharmacology       Date:  2015-11-17       Impact factor: 5.250

10.  A human laboratory pilot study with baclofen in alcoholic individuals.

Authors:  Lorenzo Leggio; William H Zywiak; John E McGeary; Steven Edwards; Samuel R Fricchione; Jessica R Shoaff; Giovanni Addolorato; Robert M Swift; George A Kenna
Journal:  Pharmacol Biochem Behav       Date:  2012-12-19       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.